Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Zhejiang Yatai Pharmaceutical Co., Ltd. operates across the entire pharmaceutical value chain, encompassing the research, development, manufacturing, sales, and global distribution of its medicinal products. The company's diverse product portfolio includes a variety of dosage forms, such as tablets, capsules, transdermal patches, powder for injection, and lozenges. Beyond finished pharmaceutical goods, Zhejiang Yatai also supplies chemical agents, essential raw materials, and diagnostic reagents. Furthermore, it extends its expertise to providing outsourced research and development services for the pharmaceutical industry. Established in 1989, Zhejiang Yatai Pharmaceutical Co., Ltd. is headquartered in Shaoxing, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI